An In-Silico Investigation on the Molecular Interactions between Ellagic Acid and PfDHFR-TS

References

• S. Sarkar, A. A. Siddiqui, S. Mazumder, R. De, S. J. Saha, C. Banerjee, M. S. Iqbal, S. Adhikari, A. Alam, S. Roy, et al. “Ellagic Acid, a Dietary Polyphenol, Inhibits Tautomerase Activity of Human Macrophage Migration Inhibitory Factor and Its Pro-Inflammatory Responses in Human Peripheral Blood Mononuclear Cells,” Journal of Agricultural and Food Chemistry 63, no. 20 (2015): 4988–98. doi:10.1021/acs.jafc.5b00921
   PubMed Web of Science ®Google Scholar
• J. Sharifi-Rad, C. Quispe, C. M. S. Castillo, R. Caroca, M. A. Lazo-Vélez, H. Antonyak, A. Polishchuk, R. Lysiuk,. P. Oliinyk, L. De Masi, et al. “Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential,” Oxidative Medicine and Cellular Longevity 2022 (2022): 3848084. doi:10.1155/2022/3848084
   PubMed Web of Science ®Google Scholar
• J. L. Ríos, R. Giner, M. Marín, and M. Recio, “A Pharmacological Update of Ellagic Acid,” Planta Medica 84, no. 15 (2018): 1068–93. doi:10.1055/a-0633-9492
   PubMed Web of Science ®Google Scholar
• P. N. Soh, B. Witkowski, D. Olagnier, M.-L. Nicolau, M. C. Garcia-Alvarez, A. Berry, and F. Benoit-Vical, “In Vitro and in Vivo Properties of Ellagic Acid in Malaria Treatment,” Antimicrobial Agents and Chemotherapy 53, no. 3 (2009): 1100–6. doi:10.1128/AAC.01175-08
   PubMed Web of Science ®Google Scholar
• P. Njomnang Soh, B. Witkowski, A. Gales, A. Huyghe, A. Berry, B. Pipy, and F. Benoit-Vical, “Implication of Glutathione in the in Vitro Antiplasmodial Mechanism of Action of Ellagic Acid,” PLoS One 7, no. 9 (2012): e45906. doi:10.1371/journal.pone.0045906
   PubMed Web of Science ®Google Scholar
• S. Mohanty, A. C. Gupta, A. K. Maurya, K. Shanker, A. Pal, and D. U. Bawankule, “Ameliorative Effects of Dietary Ellagic Acid against Severe Malaria Pathogenesis by Reducing Cytokine Storms and Oxidative Stress,” Frontiers in Pharmacology 12 (2021): 777400. doi:10.3389/fphar.2021.777400
   PubMed Web of Science ®Google Scholar
• N. Sturm, Y. Hu, H. Zimmermann, K. Fritz-Wolf, S. Wittlin, S. Rahlfs, and K. Becker, “Compounds Structurally Related to Ellagic Acid Show Improved Antiplasmodial Activity,” Antimicrobial Agents and Chemotherapy 53, no. 2 (2009): 622–30. doi:10.1128/AAC.00544-08
   PubMed Web of Science ®Google Scholar
• L. Herrmann, U. Bockau, A. Tiedtke, M. W. Hartmann, and T. Weide, “The Bifunctional Dihydrofolate Reductase Thymidylate Synthase of Tetrahymena Thermophila Provides a Tool for Molecular and Biotechnology Applications,” BMC Biotechnology 6, no. 1 (2006): 21. doi:10.1186/1472-6750-6-21
   PubMedGoogle Scholar
• B. Tarnchompoo, P. Chitnumsub, A. Jaruwat, P. J. Shaw, J. Vanichtanankul, S. Poen, R. Rattanajak, C. Wongsombat, A. Tonsomboon, S. Decharuangsilp, et al. “Hybrid Inhibitors of Malarial Dihydrofolate Reductase with Dual Binding Modes That Can Forestall Resistance,” ACS Medicinal Chemistry Letters 9, no. 12 (2018): 1235–40. doi:10.1021/acsmedchemlett.8b00389
   PubMed Web of Science ®Google Scholar
• J. H. Zothantluanga, M. Abdalla, M. Rudrapal, Q. Tian, D. Chetia, and J. Li, “Computational Investigations for Identification of Bioactive Molecules from Baccaurea Ramiflora and Bergenia Ciliata as Inhibitors of SARS-CoV-2 M Pro,” Polycyclic Aromatic Compounds 43, no. 3 (2023): 2459–87. doi:10.1080/10406638.2022.2046613
   Web of Science ®Google Scholar
• J. H. Zothantluanga, “Molecular Docking Simulation Studies, Toxicity Study, Bioactivity Prediction, and Structure-Activity Relationship Reveals Rutin as a Potential Inhibitor of SARS-CoV-2 3CL Pro,” Journal of Scientific Research 65, no. 05 (2021): 96–104. doi:10.37398/JSR.2021.650511
   Google Scholar
• M. Rudrapal, I. Celik, J. Khan, M. A. Ansari, M. N. Alomary, R. Yadav, T. Sharma, T. E. Tallei, P. K. Pasala, R. K. Sahoo, et al. “Identification of Bioactive Molecules from Triphala (Ayurvedic Herbal Formulation) as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) through Computational Investigations,” Journal of King Saud University Science 34, no. 3 (2022): 101826. doi:10.1016/j.jksus.2022.101826
   PubMed Web of Science ®Google Scholar
• J. H. Zothantluanga, N. Gogoi, A. Shakya, D. Chetia, and H. Lalthanzara, “Computational Guided Identification of Potential Leads from Acacia Pennata (L.) Willd. as Inhibitors for Cellular Entry and Viral Replication of SARS-CoV-2,” Future Journal of Pharmaceutical Sciences 7, no. 1 (2021): 201. doi:10.1186/s43094-021-00348-7
   PubMed Web of Science ®Google Scholar
• M. Rudrapal, I. Celik, S. Chinnam, M. Azam Ansari, J. Khan, S. Alghamdi, M. Almehmadi, J. H. Zothantluanga, and S. J. Khairnar, “Phytocompounds as Potential Inhibitors of SARS-CoV-2 Mpro and PLpro through Computational Studies,” Saudi Journal of Biological Sciences 29, no. 5 (2022): 3456–3465. doi:10.1016/j.sjbs.2022.02.028
   PubMed Web of Science ®Google Scholar
• S. Bhimaneni, and A. Kumar, “Abscisic Acid and Aloe-Emodin against NS2B-NS3A Protease of Japanese Encephalitis Virus,” Environmental Science and Pollution Research International 29, no. 6 (2022): 8759–66. doi:10.1007/s11356-021-16229-8
   PubMed Web of Science ®Google Scholar
• V. Navyashree, K. Kant, and A. Kumar, “Natural Chemical Entities from Arisaema Genus Might Be a Promising Break-through against Japanese Encephalitis Virus Infection: A Molecular Docking and Dynamics Approach,” Journal of Biomolecular Structure & Dynamics 39, no. 4 (2021): 1404–16. doi:10.1080/07391102.2020.1731603
   PubMed Web of Science ®Google Scholar
• K. Kant, U. R. Lal, A. Kumar, and M. Ghosh, “A Merged Molecular Docking, ADME-T and Dynamics Approaches towards the Genus of Arisaema as Herpes Simplex Virus Type 1 and Type 2 Inhibitors,” Computational Biology and Chemistry 78 (2019): 217–26. doi:10.1016/j.compbiolchem.2018.12.005
   PubMed Web of Science ®Google Scholar
• M. Sarma, M. Abdalla, J. H. Zothantluanga, F. Abdullah Thagfan, A. K. Umar, D. Chetia, T. N. Almanaa, and S. T. Al-Shouli, “Multi-Target Molecular Dynamic Simulations Reveal Glutathione-S-Transferase as the Most Favorable Drug Target of Knipholone in Plasmodium falciparum,” Journal of Biomolecular Structure & Dynamics (2023): 1–17. doi:10.1080/07391102.2023.2175378
   PubMed Web of Science ®Google Scholar
• L. L. C. Schrodinger, Schrödinger Release 2020-1: Maestro Desmond Interoperability Tools; Schrödinger (New York, NY: L.L.C.Schrodinger, 2020).
   Google Scholar
• L. L. C. Schrodinger, Release 2020-4: Desmond Molecular Dynamics System, D.E. Shaw Research, New York, NY (New York, NY: L.L.C.Schrodinger, 2020).
   Google Scholar
• K. J. Bowers, D. E. Chow, H. Xu; R, O. Dror; M, P. Eastwood; B, A. Gregersen, J. L. Klepeis, I. Kolossvary; M, A. Moraes; F, D. Sacerdoti, et al. “Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters” (paper presented at the ACM/IEEE SC 2006 Conference (SC’06), pp 43–43, Tampa, FL, 11–17 November 2006).
   Google Scholar
• M. S. Zubair, S. Maulana, A. Widodo, R. Pitopang, M. Arba, and M. Hariono, “GC-MS, LC-MS/MS, Docking and Molecular Dynamics Approaches to Identify Potential SARS-CoV-2 3-Chymotrypsin-Like Protease Inhibitors from Zingiber Officinale Roscoe,” Molecules 26, no. 17 (2021): 5230. doi:10.3390/molecules26175230
   PubMed Web of Science ®Google Scholar
• J. H. Zothantluanga, S. K. Aswin,  Rudrapal, and D. Cheita, “Antimalarial Flavonoid-Glycoside from Acacia Pennata with Inhibitory Potential against PfDHFR-TS: An in-Silico Study,” Biointerface Research in Applied Chemistry 12, no. 4 (2022): 4871–87. doi:10.33263/BRIAC124.48714887
   Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7, no. 1 (2017): 42717. doi:10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• P. Banerjee, A. O. Eckert, A. K. Schrey, and R. Preissner, “ProTox-II: A Webserver for the Prediction of Toxicity of Chemicals,” Nucleic Acids Research 46, no. W1 (2018): W257–63. doi:10.1093/nar/gky318
   PubMed Web of Science ®Google Scholar
• T. Sander, J. Freyss, M. von Korff, and C. Rufener, “DataWarrior: An Open-Source Program for Chemistry Aware Data Visualization and Analysis,” Journal of Chemical Information and Modeling 55, no. 2 (2015): 460–73. doi:10.1021/ci500588j
   PubMed Web of Science ®Google Scholar
• N. Chaianantakul, R. Sirawaraporn, and W. Sirawaraporn, “Insights into the Role of the Junctional Region of Plasmodium falciparum Dihydrofolate Reductase-Thymidylate Synthase,” Malaria Journal 12, no. 1 (2013): 91. doi:10.1186/1475-2875-12-91
   PubMedGoogle Scholar
• L. K. Kyei, E. N. Gasu, G. B. Ampomah, J. O. Mensah, and L. S. Borquaye, “An in Silico Study of the Interactions of Alkaloids from Cryptolepis Sanguinolenta with Plasmodium falciparum Dihydrofolate Reductase and Dihydroorotate Dehydrogenase,” Journal of Chemistry 2022 (2022): 1–26. doi:10.1155/2022/5314179
   Web of Science ®Google Scholar
• Y. Melaku, M. Solomon, R. Eswaramoorthy, U. Beifuss, V. Ondrus, and Y. Mekonnen, “Synthesis, Antiplasmodial Activity and in Silico Molecular Docking Study of Pinocembrin and Its Analogs,” BMC Chemistry 16, no. 1 (2022): 36. doi:10.1186/s13065-022-00831-z
   PubMed Web of Science ®Google Scholar
• P. M. Quan, L. T. T. Huong; T, Q. Toan; N, P. Hung; P, H. Nam; N, T. Kiet; N, X. Ha; D, T. T. Le; T, N. T. An; P, L. Show, et al. “Cannabis Sativa L. Chemical Compositions as Potential Plasmodium falciparum Dihydrofolate Reductase-Thymidinesynthase Enzyme Inhibitors: An in Silico Study for Drug Development,” Open Chemistry 19, no. 1 (2021): 1235–41. doi:10.1515/chem-2021-0102
   Web of Science ®Google Scholar
• N. Nagasundaram, C. George Priya Doss, C. Chakraborty, V. Karthick, D. Thirumal Kumar, V. Balaji, A. Lu, Z. Ge, and H. Zhu, “Mechanism of Artemisinin Resistance for Malaria PfATP6 L263 Mutations and Discovering Potential Antimalarials: An Integrated Computational Approach,” Scientific Reports 6, no. 1 (2016) : 30106. doi:10.1038/srep30106
   PubMedGoogle Scholar
• M. Thillainayagam, K. Malathi, and S. Ramaiah, “In - Silico Molecular Docking and Simulation Studies on Novel Chalcone and Flavone Hybrid Derivatives with 1, 2, 3-Triazole Linkage as Vital Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase,” Journal of Biomolecular Structure & Dynamics 36, no. 15 (2018): 3993–4009. doi:10.1080/07391102.2017.1404935
   PubMed Web of Science ®Google Scholar
• A. M. Dhote, V. R. Patil, D. K. Lokwani, N. D. Amnerkar, V. G. Ugale, N. B. Charbe, B. A. Bhongade, and S. C. Khadse, “Strategic Analyses to Identify Key Structural Features of Antiviral/Antimalarial Compounds for Their Binding Interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: In Silico Molecular Docking and Dynamic Simulation Studies,” Journal of Biomolecular Structure & Dynamics 40, no. 22 (2022): 11914–31. doi:10.1080/07391102.2021.1965912
   PubMed Web of Science ®Google Scholar
• A. K. Umar, J. H. Zothantluanga, K. Aswin, S. Maulana, M. Sulaiman Zubair, H. Lalhlenmawia, M. Rudrapal, and D. Chetia, “Antiviral Phytocompounds “Ellagic Acid” and “(+)-Sesamin” of Bridelia Retusa Identified as Potential Inhibitors of SARS-CoV-2 3CL Pro Using Extensive Molecular Docking, Molecular Dynamics Simulation Studies, Binding Free Energy Calculations, and Bioactivi,” Structural Chemistry 33, no. 5 (2022): 1445–65. doi:10.1007/s11224-022-01959-3
   PubMed Web of Science ®Google Scholar
• I. M. M. Othman, M. H. Mahross, M. A. M. Gad-Elkareem, M. Rudrapal, N. Gogoi, D. Chetia, K. Aouadi, M. Snoussi, and A. Kadri, “Toward a Treatment of Antibacterial and Antifungal Infections: Design, Synthesis and in Vitro Activity of Novel Arylhydrazothiazolylsulfonamides Analogues and Their Insight of DFT, Docking and Molecular Dynamic Simulations,” Journal of Molecular Structure 1243 (2021): 130862. doi:10.1016/j.molstruc.2021.130862
   Web of Science ®Google Scholar
• A. Daina, and V. Zoete, “A BOILED-Egg to Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules,” Chemmedchem 11, no. 11 (2016): 1117–21. doi:10.1002/cmdc.201600182
   PubMed Web of Science ®Google Scholar
• Y. Duarte, M. Rojas, J. Canan, E. G. Pérez, F. González-Nilo, and J. García-Colunga, “Different Classes of Antidepressants Inhibit the Rat Α7 Nicotinic Acetylcholine Receptor by Interacting within the Ion Channel: A Functional and Structural Study,” Molecules 26, no. 4 (2021): 998. doi:10.3390/molecules26040998
   PubMed Web of Science ®Google Scholar
• D. Chen, N. Oezguen, P. Urvil, C. Ferguson, S. M. Dann, and T. C. Savidge, “Regulation of Protein-Ligand Binding Affinity by Hydrogen Bond Pairing,” Science Advances 2, no. 3 (2016) : e1501240. doi:10.1126/sciadv.1501240
   PubMed Web of Science ®Google Scholar
• A. Mahmoud, A. Mostafa, A. A. Al-Karmalawy, A. Zidan, H. S. Abulkhair, S. H. Mahmoud, M. Shehata, M. M. Elhefnawi, and M. A. Ali, “Telaprevir is a Potential Drug for Repurposing against SARS-CoV-2: Computational and in Vitro Studies,” Heliyon 7, no. 9 (2021): e07962. doi:10.1016/j.heliyon.2021.e07962
   PubMed Web of Science ®Google Scholar
• J. H. Zothantluanga, and D. Chetia, “A Beginner’s Guide to Molecular Docking,” Sciences of Phytochemistry 1, no. 2 (2022): 37–40. doi:10.58920/sciphy01020037
   Google Scholar
• J. Li, R. Abel, K. Zhu, Y. Cao, S. Zhao, and R. A. Friesner, “The VSGB 2.0 Model: A Next Generation Energy Model for High Resolution Protein Structure Modeling,” Proteins 79, no. 10 (2011): 2794–812. doi:10.1002/prot.23106
   PubMed Web of Science ®Google Scholar